RSV vaccine costs raise concerns

As the rollout of the Respiratory Syncytial Virus (RSV) vaccine gains momentum, concerns are emerging regarding accessibility and potential costs for vulnerable populations.

Top Videos

Watch Full Episodes

Good Day New York